The estimated Net Worth of Jerome M Hauer is at least 2.91 百万$ dollars as of 26 May 2020. Jerome Hauer owns over 4,385 units of Emergent Biosolutions Inc stock worth over 77,123$ and over the last 18 years he sold EBS stock worth over 2,481,956$. In addition, he makes 352,500$ as Independent Director at Emergent Biosolutions Inc.
Jerome has made over 13 trades of the Emergent Biosolutions Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 4,385 units of EBS stock worth 373,383$ on 26 May 2020.
The largest trade he's ever made was selling 10,776 units of Emergent Biosolutions Inc stock on 15 August 2017 worth over 386,104$. On average, Jerome trades about 2,211 units every 106 days since 2006. As of 26 May 2020 he still owns at least 10,188 units of Emergent Biosolutions Inc stock.
You can see the complete history of Jerome Hauer stock trades at the bottom of the page.
Dr. Jerome M. Hauer, Ph.D., is an Independent Director of the Company. He previously served on our Board of Directors from May 2004 to October 2011. Currently, Dr. Hauer is a senior advisor at Teneo Risk in New York City and Washington, D.C. and a visiting professor at Cranfield University/Defence Academy of the United Kingdom. Before joining Teneo Risk, Dr. Hauer served from January 2012 until December 2014 as the Commissioner of New York State Division of Homeland Security and Emergency Services and Chairman of the Executive Committee on Counterterrorism. Formerly, Dr. Hauer served as chief executive officer of The Hauer Group from 2006 to 2011 and as senior vice president and co-chair of the homeland security practice of Fleishman-Hillard Government Relations from January 2005 to March 2006. Prior to joining Fleishman-Hillard, Dr. Hauer served as acting assistant secretary for the office of public health emergency preparedness at HHS from June 2002 to November 2003 and as director of the office of public health preparedness of HHS from May 2002 to June 2002. Dr. Hauer served as the first director of the New York City Mayor's Office of Emergency Management under Mayor Rudolph Giuliani. He also served as the director of Emergency Medical Services and Emergency Management as well as director of the Department of Fire and Buildings for the State of Indiana under Governor Evan Bayh. Dr. Hauer holds a Ph.D. from Cranfield University/Defence Academy of the United Kingdom. He received an M.H.S. in public health from Johns Hopkins University School of Hygiene and Public Health and a B.A. from New York University. Hauer's qualifications to serve on our Board of Directors include his significant experience in various governmental and public health organizations, as well as his experience on other boards.
As the Independent Director of Emergent Biosolutions Inc, the total compensation of Jerome Hauer at Emergent Biosolutions Inc is 352,500$. There are 14 executives at Emergent Biosolutions Inc getting paid more, with Robert Kramer having the highest compensation of 3,693,820$.
Jerome Hauer is 68, he's been the Independent Director of Emergent Biosolutions Inc since 2015. There are 5 older and 16 younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
Jerome's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over 131,382,266$ worth of Emergent Biosolutions Inc stock and bought 4,647 units worth 138,981$ . The most active insiders traders include Seamus Mulligan、Fuad El Hibri、Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of 147,206$. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth 61,100$.
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include: